ABUS vs CF
Arbutus Biopharma Corp (ABUS) versus CF Industries Holdings Inc (CF) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Not investment advice. Open the ABUS and CF stock pages for the full models.
Not investment advice.